We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Siemens and Biosense Webster Extend Catheter Distribution Agreement

By MedImaging staff writers
Posted on 02 Feb 2007
Print article
Siemens Medical Solutions (Erlangen, Germany) and Biosense Webster, Inc. (Diamond Bar, CA, USA) announced an extension of their strategic alliance to now give Biosense Webster exclusive worldwide rights to distribute Siemens' Acuson AcuNav ultrasound catheters to interventional cardiologists.

Earlier in 2007, Biosense Webster was granted exclusive distribution rights to market the catheter to electrophysiologists. The Siemens AcuNav ultrasound catheters provide physicians with high-quality diagnostic images and Doppler blood flow data throughout the entire heart during a cardiac catheterization procedure. Approved for marketing in 1999, AcuNav ultrasound catheters are known for state-of-the-art quality.

"The integration of these two industry leaders, both focused on providing high quality intracardiac echocardiography products, will help physicians improve care for the cardiac patient,” said Robert J. Sommer, M.D., New York-Presbyterian Hospital/Columbia University Medical Center (New York, NY, USA). "Clinicians are looking forward to the innovative products that this collaboration will provide to the medical community.”

Biosense Webster is a major player in the electrophysiology and interventional cardiology market and Siemens is an ultrasound industry leader. This expanded strategic alliance will enable both two companies to address the real-time imaging needs of interventional cardiologists.

"We are pleased to extend this strategic alliance with Siemens Medical Solutions Ultrasound Division into the interventional cardiology market. This agreement provides additional opportunities to collaborate with our partners at Siemens to bring to market innovative solutions in electrophysiology and interventional cardiology,” said Roy Tanaka, president, Biosense Webster. "Together, Biosense Webster and Siemens will better serve the needs of cardiologists around the world to help millions of patients each year who suffer from cardiovascular disease.”

Biosense Webster pioneered electrophysiology diagnostic catheters more than 30 years ago and continues to provide advanced diagnostic, therapeutic, and mapping tools.



Related Links:
Siemens Medical Solutions
Biosense Webster
Multi-Use Ultrasound Table
Clinton
Computed Tomography System
Aquilion ONE / INSIGHT Edition
New
Biopsy Software
Affirm® Contrast
New
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector

Print article

Channels

Radiography

view channel
Image: The new machine algorithm can identify cardiovascular risk at the click of a button (Photo courtesy of Adobe Stock)

Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans

A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more

MRI

view channel
Image: In brains of control mice (left) and PD mice (right), from bottom to top: neuronal activity in a representative animal (Photo courtesy of Ruxanda Lungu/FC)

Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable

Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.